PeptiCRAd – Flexible Peptide Delivery Platform for Therapeutic Cancer (Neoantigen) Vaccines

Time: 4:00 pm
day: Day One


• Reviewing how the safety and efficacy of these vaccine modalities remains unclear in certain cancer patients

• Addressing the complex manufacturing process and regulatory aspects

• Developing neoantigen vaccines based on peptides and viral adjuvants